Fox P K, Connick J H, Hanlon G M, France L, Nicholson C D
Department of Pharmacology, Organon Laboratories Limited, Newhouse, Lanarkshire, U.K.
Eur J Pharmacol. 1991 Feb 7;193(2):139-43. doi: 10.1016/0014-2999(91)90028-o.
The present study examined the utility of the rat vas deferens preparation as a bioassay for sigma site ligands. sigma Ligands such as (+/-)-pentazocine, phencyclidine (PCP) and (+)-SK&F 10047 potentiated neurogenic twitch contractions. However, neither the order of potency nor the absolute potency of (+/-)-pentazocine and (+)-SK&F 10047 correlated with their affinity at central sigma sites. Furthermore, another potent sigma ligand, ditolyl-ortho guanidine (DTG) neither affected neurogenic twitch contractions nor inhibited twitch potentiation by PCP or (+)-SK&F 10047 at concentrations up to 30 mumol/l. These data indicate that the rat vas deferens is not a useful bioassay for the evaluation of sigma ligands. PCP, (+)-SK&F 10047 and (+/-)-pentazocine probably enhance neurogenic contractions in rat vas deferens primarily by inhibition of the neuronal uptake of noradrenaline.
本研究检测了大鼠输精管制备物作为σ位点配体生物测定法的效用。σ配体如(±)-喷他佐辛、苯环利定(PCP)和(+)-SK&F 10047可增强神经源性抽搐收缩。然而,(±)-喷他佐辛和(+)-SK&F 10047的效价顺序和绝对效价均与其在中枢σ位点的亲和力无关。此外,另一种强效σ配体二邻甲苯基胍(DTG)在浓度高达30μmol/L时,既不影响神经源性抽搐收缩,也不抑制PCP或(+)-SK&F 10047引起的抽搐增强。这些数据表明,大鼠输精管不是评估σ配体的有用生物测定法。PCP、(+)-SK&F 10047和(±)-喷他佐辛可能主要通过抑制去甲肾上腺素的神经元摄取来增强大鼠输精管的神经源性收缩。